Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Aug 2;117 Suppl 3A(3):39S-50S.
doi: 10.1016/j.amjmed.2004.07.007.

Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern

Affiliations
Review

Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern

Thomas M File Jr. Am J Med. .

Abstract

Community-acquired pneumonia (CAP) is the sixth most common cause of death in the United States and the leading cause of death from infectious diseases. It is associated with significant morbidity and mortality, and poses a major economic burden to the healthcare system. Streptococcus pneumoniae is the leading cause of CAP. Other common bacterial causes include Haemophilus influenzae as well as atypical bacteria (Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella species). Increasing resistance to a variety of antimicrobial agents has been documented in S. pneumoniae and is common in H. influenzae as well. Successful empiric therapy is paramount to the management of CAP to avoid treatment failure and subsequent associated costs. Given that resistance is increasing among respiratory pathogens, and S. pneumoniae is the most common etiologic agent identified in CAP, strategies for antimicrobial therapy should be based on the likely causative pathogen, the presence of risk factors for infection with resistant bacteria, and local resistance patterns.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Age-specific rates of community-acquired pneumonia caused by specific pathogens. (Reprinted with permission from Arch Intern Med.4)
Figure 2
Figure 2
Trends in penicillin resistance among Streptococcus pneumoniae in the United States. *Number of centers contributing isolates. MIC = minimum inhibitory concentration. (Courtesy of G. V. Doern, personal communication, December 2002.)
Figure 3
Figure 3
Increasing Streptococcus pneumoniae resistance in response to increased use of penicillin. (Reprinted with permission from J Antimicrob Chemother.55)
Figure 4
Figure 4
Outcomes for 192 hospitalized patients with pneumococcal pneumonia. *Statistically significant, unadjusted for other risk factors (when adjusted for other risk factors, the only outcome with significant differences was suppurative complications). ICU = intensive care unit; RR = unadjusted relative risk, Cochran-Mantel-Haenszel statistics. (Adapted from Clin Infect Dis.62)

Similar articles

Cited by

References

    1. File T.M., Jr Community-acquired pneumonia. Lancet. 2003;362:1991–2001. - PMC - PubMed
    1. Murphy SL. Deaths: Final Data for 1998. Hyattsville, MD: US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2000. National Vital Statistics Reports, Volume 48, No. 11. DHHS publication no. PHS 2000-1120 - PubMed
    1. Centers for Disease Control and Prevention Premature deaths, monthly mortality, and monthly physician contacts: United States. MMWR Morb Mortal Wkly Rep. 1997;46:556–561. - PubMed
    1. Marston B.J, Plouffe J.F, File T.M, Jr, Community-Based Pneumonia Incidence Study Group Incidence of community-acquired pneumonia requiring hospitalization. Arch Intern Med. 1997;157:1709–1718. - PubMed
    1. Fine M.J, Auble T.E, Yealy D.M. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–250. - PubMed

MeSH terms

Substances